Pear Therapeutics inks multiple agreements to expand digital therapeutic platform

Pear Therapeutics announced today that it entered into multiple agreements to bolster its prescription digital therapeutics (PDT) platform.

Boston-based Pear Therapeutics’ agreements are set to add to its library of digital biomarkers, machine learning algorithms, sensor-based technologies and digital therapeutics, according to a news release.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0